Researchers have shown, in unprecedented detail, how a small molecule is able to selectively take apart abnormally folded protein fibers connected to Alzheimer's disease and prion diseases.

Nektar Therapeutics announced initial results today from a Phase 1 study of NKTR- 102, PEGylated irinotecan. The data shows significant anti-tumor activity in patients with refractory solid tumors.

The CDC has concluded an investigation of a clinic in Nevada that reported an outbreak of Hepatitis C Virus (HCV) in 6 people that resulted from unsafe injection procedures.

Lung cancer patients whose histology is factored into treatment decisions may fare better as a result.

The investigational chemotherapeutic agent eribulin mesylate demonstrated activity in a heavily pretreated population of women with locally advanced or metastatic breast cancer.

BARRX Medical announced that 90.2 percent of the patients in a multi-center US study were free of the highest-risk of Barrett's esophagus after having a non-surgical, endoscopic treatment using the HALO360 ablation system.

An area hearing specialist is making sure more and more people around the Northwoods get their hearing checked, and he's...

Five-year old Yussuf's life was virtually meaningless till he underwent a cochlear implant surgery that helped him overcome the problem...

Federal Signal Corporation (NYSE: FSS - News) announced today that the Missouri firefighter plaintiffs voluntarily dismissed their hearing loss claims....

Local Shell Beach resident, 13-year-old Meghan Martin, donated half of the proceeds from her 4-H Lamb Project to Jack's Assistance...

It is within thy power, whenever thou shalt choose, to retire into thyself. For nowhere either with more quiet or more freedom from trouble does a man retire than into his own soul.

The continuing emphasis on research and education at Minnesota Eye Consultants, supported by the extraordinary achievements of its partners, has helped to expand the medical and surgical options available today. Here surgeons can discuss the potential benefits and risks of

LONDON and SAN DIEGO, CA -- Antisoma plc announces that new preclinical data on its anti-nucleolin aptamer drug AS1411 are presented today at the American Association for Cancer Research (AACR) meeting in San Diego, CA. The presentation shows that AS1411

Let the waters settle you will see stars and moon mirrored in your Being, Spirituality

Attendees to Learn How to Facilitate Cost-Effective, Worldwide Learning and Collaboration Business Wire - May 16, 2008 http://www.aegis.org/news/bw/2008/BW080523.html [HR noShade SI ...

UN Integrated Regional Information Network - May 16, 2008 http://www.aegis.org/news/irin/2008/IR080518.htmlBUJUMBURA, 16 May 2008 (PlusNews) - A new HIV prevention campaign targ ...

Bay Windows - May 15, 2008 Ethan Jacobs, ejacobs@baywindows.com http://www.aegis.org/news/bayw/2008/BY080505.html A former patient of Caritas St. Elizabeth's Med ...

The New York Times - May 16, 2008 Gretel C. Kovach http://www.aegis.org/news/nyt/2008/NYT080505.html DALLAS - A homeless man who spit in the mouth and eye ...

Food and Drug Administration - May 16, 2008Richard Klein & Kimberly Strublehttp://www.aegis.org/news/fda/2008/FD080501.html On Ma ...

National Institute of Allergy and Infectious Diseases; National Institutes of HealthNIAID Online Update - May 12, 2008 http://www.aegis.org/news/niaid/2008/NI080501.htmlThe ...